Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stocks in news: TCS, Groww, Shriram Finance, Dixon Tech, Anand Rathi Wealth
Indian markets saw a rebound on Thursday, recovering from Wednesday's sharp sell-off. TCS reported a 5% year-on-year profit growth, and Groww affirmed its direct mutual fund strategy. Shriram Finance is raising funds to reduce borrowing costs after a rating upgrade. Maruti Suzuki plans to add service points, and Dixon Tech will expand smartphone manufacturing. Premier Energies commissioned a solar module facility, and Anand Rathi Wealth saw profit rise.
Sensex Today | Nifty 50 | Stock Market Live Updates: Sensex rises over 150 pts, Nifty above 23,900; M&M, Adani Ports up 2% each - The Economic Times
Sensex Today | Nifty 50 | Stock Market Live Updates: Sensex rises over 150 pts, Nifty above 23,900; M&M, Adani Ports up 2% eachThe Economic TimesClosing Bell: Sensex, Nifty end lower in volatile June expiry session; pharma, realty buck trendMoneycontrol.comSensex today | Stock Market Live: Sensex rises 500 pts, Nifty crosses 24,000; KPIT hits 52-week low, tanks 15%BusinessLine
Nifty 50 index slides below 23,950 level; auto shares outperform as Maruti Suzuki leads charge
The key equity benchmarks continued to trade below the flat line in afternoon trade. The Nifty 50 index traded below the 23,950 level. Auto, pharma and realty index advanced while IT, banks and FMCG stocks declined.
Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent Systems
Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving averages, with a decisive close above 24,200 crucial for further gains. Several companies like Waaree Energies, Kotak Bank, and Tata Motors are in focus due to significant developments, including US investigations, strategic partnerships, and EV expansion plans.
Nifty has more room to run; stay selective: Analysts
Indian stock markets are showing cautious optimism, with the Nifty eyeing the 24,300-25,000 zone amid ongoing volatility. Analysts recommend selective trading and specific strategies like a moderately bullish Call Spread. Top stock picks include TVS Motor, Samvardhana Motherson International, Oberoi Realty, Aurobindo Pharma, Vijaya Diagnostic Centre, and Mahindra & Mahindra Financial Services, each presenting unique buying opportunities with defined targets and stop losses.
Stocks to buy: Aurobindo Pharma, Delhivery, Ather Energy, says Ajit Mishra
Market outlook by Ajit Mishra: The analyst from Religare Broking expects Nifty to consolidate in the near-term; among stocks he recommends Delhivery, Ather Energy and Aurobindo Pharma.

39 NIFTY 500 stocks that delivered consistent growth over 5 years; Natco Pharma, ABB, M&M among top picks - Upstox
39 NIFTY 500 stocks that delivered consistent growth over 5 years; Natco Pharma, ABB, M&M among top picksUpstox

Stocks to watch: Sun Pharma, Nestle India, Bharat Forge among shares in focus today; check list here
Stock market today: On Friday, the Sensex fell 607.08 points, or 0.78%, to finish at 76,802.90, while the Nifty 50 slipped 154.90 points, or 0.64%, to settle at 24,013.10.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.

NLC India shares in focus as government's Offer For Sale opens for non-retail investors
Among the public shareholders, mutual funds of India had a 9.49% stake in NLC India, led mainly by Nippon Life India AMC (5.65%) and Kotak Mahindra MF (2.6%). The stock is up over 30% so far in 2026.